​

PROCEPT BioRobotics (PRCT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PRCT Stock Forecast

PROCEPT BioRobotics (PRCT) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $60.00, with a high of $60.00 and a low of $60.00. This represents a 55.28% increase from the last price of $38.64.

$35 $48 $61 $74 $87 $100 High: $60 Avg: $60 Low: $60 Last Closed Price: $38.64

PRCT Stock Rating

PROCEPT BioRobotics stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (85.71%), 2 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 2 12 Strong Sell Sell Hold Buy Strong Buy

PRCT Price Target Upside V Benchmarks

TypeNameUpside
StockPROCEPT BioRobotics55.28%
SectorHealthcare Stocks 13.55%
IndustryMedical Device Stocks14.97%

Price Target Trends

1M3M12M
# Anlaysts113
Avg Price Target$60.00$60.00$90.00
Last Closing Price$38.64$38.64$38.64
Upside/Downside55.28%55.28%132.92%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 25273--12
Aug, 25273--12
Jul, 25262--10
Jun, 25262--10
May, 25262--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 02, 2025Suraj KaliaOppenheimer$60.00$41.5844.30%55.28%
Dec 02, 2024Patrick WoodMorgan Stanley$105.00$94.9310.61%171.74%
Oct 29, 2024Richard NewitterTruist Financial$105.00$96.249.10%171.74%
Sep 03, 2024Richard NewitterTruist Financial$95.00$79.0020.25%145.86%
Jul 16, 2024Richard NewitterTruist Financial$79.00$68.9014.66%104.45%
May 06, 2024Matt O'BrienPiper Sandler$75.00$64.3116.62%94.10%
May 02, 2024Richard NewitterTruist Financial$72.00$60.6118.79%86.34%
Sep 02, 2022Nathan TreybeckWells Fargo$49.00$40.3821.35%26.81%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 02, 2025OppenheimerPerformOutperformupgrade
Jul 07, 2025OppenheimerPerforminitialise
Dec 02, 2024Morgan StanleyOverweightinitialise
Oct 29, 2024BTIGNeutralNeutralhold
Oct 28, 2024William BlairOutperformOutperformhold
Oct 08, 2024Truist FinancialUnderperformUnderperformhold
Sep 16, 2024Cowen & Co.BuyBuyhold
Jul 02, 2024Cowen & Co.BuyBuyhold
May 06, 2024Cowen & Co.BuyBuyhold
May 06, 2024Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.43$-2.11$-2.24$-1.75----
Avg Forecast$-3.04$-1.88$-2.14$-1.74$-1.30$-0.76$-0.02$0.56
High Forecast$-2.93$-1.81$-2.08$-1.69$-1.04$-0.56$-0.02$0.58
Low Forecast$-3.12$-1.95$-2.23$-1.83$-1.55$-1.05$-0.02$0.54
Surprise %-52.96%12.23%4.67%0.57%----

Revenue Forecast

$0 $130M $260M $390M $520M $650M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$34.47M$75.01M$136.19M$224.50M----
Avg Forecast$33.37M$74.15M$134.44M$223.93M$315.00M$415.28M$516.98M$624.64M
High Forecast$34.07M$76.43M$138.14M$224.04M$318.36M$416.43M$528.59M$641.83M
Low Forecast$32.44M$72.02M$129.50M$223.77M$311.07M$414.13M$505.38M$601.68M
Surprise %3.31%1.16%1.30%0.25%----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.38M$-93.58M$-105.90M$-91.41M----
Avg Forecast$-143.66M$-88.84M$-101.72M$-83.22M$-70.45M$-43.55M$-1.10M$26.62M
High Forecast$-138.46M$-85.51M$-98.19M$-79.93M$-49.23M$-26.33M$-1.05M$27.57M
Low Forecast$-147.59M$-92.38M$-105.24M$-86.51M$-73.37M$-49.54M$-1.14M$25.35M
Surprise %-56.57%5.34%4.11%9.85%----

PRCT Forecast FAQ

Is PROCEPT BioRobotics stock a buy?

PROCEPT BioRobotics stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that PROCEPT BioRobotics is a favorable investment for most analysts.

What is PROCEPT BioRobotics's price target?

PROCEPT BioRobotics's price target, set by 14 Wall Street analysts, averages $60 over the next 12 months. The price target range spans from $60 at the low end to $60 at the high end, suggesting a potential 55.28% change from the previous closing price of $38.64.

How does PROCEPT BioRobotics stock forecast compare to its benchmarks?

PROCEPT BioRobotics's stock forecast shows a 55.28% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and outperforming the medical device stocks industry (14.97%).

What is the breakdown of analyst ratings for PROCEPT BioRobotics over the past three months?

  • September 2025: 16.67% Strong Buy, 58.33% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 16.67% Strong Buy, 58.33% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is PROCEPT BioRobotics’s EPS forecast?

PROCEPT BioRobotics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.3, marking a -25.71% decrease from the reported $-1.75 in 2024. Estimates for the following years are $-0.76 in 2026, $-0.02 in 2027, and $0.56 in 2028.

What is PROCEPT BioRobotics’s revenue forecast?

PROCEPT BioRobotics's average annual revenue forecast for its fiscal year ending in December 2025 is $315M, reflecting a 40.32% increase from the reported $224.5M in 2024. The forecast for 2026 is $415.28M, followed by $516.98M for 2027, and $624.64M for 2028.

What is PROCEPT BioRobotics’s net income forecast?

PROCEPT BioRobotics's net income forecast for the fiscal year ending in December 2025 stands at $-70.45M, representing a -22.93% decrease from the reported $-91.413M in 2024. Projections indicate $-43.549M in 2026, $-1.096M in 2027, and $26.62M in 2028.